{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:27:21Z","timestamp":1791217641058,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5977,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.nurt.2007.01.005","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T07:19:14Z","timestamp":1175066354000},"page":"233-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Management and Treatment of Andersen-Tawil Syndrome (ATS)"],"prefix":"10.1016","volume":"4","author":[{"given":"Valeria","family":"Sansone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi","family":"Tawil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2007.01.005_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1651-2227.1971.tb06990.x","article-title":"Intermittent muscular weakness, extrasystoles, and multiple developmental abnormalities: a new syndrome?","volume":"60","author":"Andersen","year":"1971","journal-title":"Acta Pediatr Scand"},{"key":"10.1016\/j.nurt.2007.01.005_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410350313","article-title":"Andersen\u2019s syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features","volume":"35","author":"Tawil","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.005_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.410420306","article-title":"Andersen\u2019s syndrome: a distinct periodic paralysis","volume":"42","author":"Sansone","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.005_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1096-8628(19990716)85:2<147::AID-AJMG9>3.0.CO;2-0","article-title":"Andersen syndrome autosomal dominant in three generations","volume":"85","author":"Canun","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nurt.2007.01.005_bib5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen\u2019s syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2007.01.005_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.01.005_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.hrthm.2006.03.025","article-title":"Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing","volume":"3","author":"Tester","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nurt.2007.01.005_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/342360","article-title":"KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes","volume":"71","author":"Andelfinger","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2007.01.005_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/01.wnl.0000178888.03767.74","article-title":"Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation","volume":"65","author":"Davies","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.005_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1067\/mhj.2002.120295","article-title":"Long QT syndrome: diagnosis and management","volume":"143","author":"Khan","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.nurt.2007.01.005_bib11","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.nurt.2007.01.005_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.hrthm.2005.11.026","article-title":"Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7)","volume":"3","author":"Tsuboi","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nurt.2007.01.005_bib13","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.hrthm.2006.07.021","article-title":"A family with Andersen-Tawil syndrome and dilated cardiomyopathy","volume":"3","author":"Schoonderwoerd","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nurt.2007.01.005_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mus.880090805","article-title":"The exercise test in periodic paralysis","volume":"9","author":"McManis","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2007.01.005_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.20241","article-title":"Electromyography guides toward subgroups of mutations in muscle channelopathies","volume":"56","author":"Fournier","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.005_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneur.56.3.352","article-title":"The exercise test in Andersen syndrome","volume":"56","author":"Katz","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2007.01.005_bib17","doi-asserted-by":"crossref","first-page":"R747","DOI":"10.1016\/S0960-9822(01)00437-7","article-title":"Channelopathies: Kir2.1 mutations jeopardize many cell functions","volume":"11","author":"Jongsma","year":"2001","journal-title":"Curr Biol"},{"key":"10.1016\/j.nurt.2007.01.005_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/jmcc.2001.1344","article-title":"Inward rectifiers in the heart: an update on Ik1","volume":"1","author":"Lopatin","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nurt.2007.01.005_bib19","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1073\/pnas.122682899","article-title":"A glutamate residue at the C-terminus regulates activity of inward rectifier K+ channels: implication for Andersen\u2019s syndrome","volume":"99","author":"Chen","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2007.01.005_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-2828(03)00046-4","article-title":"Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen\u2019s syndrome","volume":"35","author":"Hosaka","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nurt.2007.01.005_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/01.WNL.0000072261.14060.47","article-title":"PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome","volume":"60","author":"Donaldson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.005_bib22","doi-asserted-by":"crossref","first-page":"51779","DOI":"10.1074\/jbc.M310278200","article-title":"Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome","volume":"278","author":"Bendahhou","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2007.01.005_bib23","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1073\/pnas.102609499","article-title":"Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen\u2019s syndrome","volume":"99","author":"Preisig-Muller","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2007.01.005_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/17431380410032490","article-title":"Andersen-Tawil syndrome: a model of clinical variability, pleiotropy and genetic heterogeneity","volume":"36","author":"Donaldson","year":"2004","journal-title":"Ann Med"},{"key":"10.1016\/j.nurt.2007.01.005_bib25","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1212\/01.wnl.0000218214.64942.64","article-title":"Andersen-Tawil syndrome: definition of a neurocognitive phenotype","volume":"66","author":"Yoon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.005_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0197-2456(90)90003-K","article-title":"N of 1 randomized trials for investigating new drugs","volume":"11","author":"Guyatt","year":"1990","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.nurt.2007.01.005_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H","article-title":"Randomized trials of dichlorphenamide in the periodic paralyses","volume":"47","author":"Tawil","year":"2000","journal-title":"Ann Neurol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2007.01.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:38:18Z","timestamp":1761806298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923006591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1878747923006591"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2007.01.005","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management and Treatment of Andersen-Tawil Syndrome (ATS)","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2007.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}